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Edited by Miguel De la RosaAbstract Cytochrome bd catalyzes the two-electron oxidation
of either ubiquinol or menaquinol and the four-electron reduction
of O2 to H2O. In the current work, the rates of reduction of the
fully oxidized and oxoferryl forms of the enzyme by the 2-elec-
tron donor ubiquinol-1 and single electron donor N,N,N 0,N 0-tet-
ramethyl-p-phenylendiamine (TMPD) have been examined by
stopped-ﬂow techniques. Reduction of the all-ferric form of the
enzyme is 1000-fold slower than required for a step in the cata-
lytic cycle, whereas the observed rates of reduction of the oxofer-
ryl and singly-reduced forms of the cytochrome are consistent
with the catalytic turnover. The data support models of the cat-
alytic cycle which do not include the fully oxidized form of the
enzyme as an intermediate.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The cytochrome bd quinol oxidase is one of the two terminal
oxidases in the respiratory chain of E. coli, and catalyzes the 2-
electron oxidation of either menaquinol or ubiquinol and the
four-electron reduction of oxygen to water [1–5]. This enzyme
is a member of a large family of respiratory oxidases that are
found in many prokaryotes, both bacteria and archaea. There
is no eukaryotic homologue, and the presence of bd-type oxi-
dases in a number of human pathogens makes this enzyme a
possible drug target. Cytochrome bd is a transmembrane het-
erodimer, with one copy each of two proteins coded by the
genes CydA (subunit I; 58 kDa) and CydB (subunit II;
43 kDa) [6]. There is no sequence homology between cyto-
chrome bd and the large superfamily of the heme–copper respi-
ratory oxidases [7], and the bd-type oxidases do not contain
copper [6]. During turnover, cytochrome bd does not pump
protons but it generates a proton motive force due to the fact
that the protons used in the reaction to make H2O come fromAbbreviations: TMPD, N,N,N0,N0-tetramethyl-p-phenylendiamine;
DTT, dithiothreitol; EDTA, ethylenediaminetetraacetic acid; UQH2-
1, ubiquinol-1
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tion of QH2, which is oxidized near the opposite side of the
membrane, are released to the periplasm [8,9].
Cytochrome bd contains three heme prosthetic groups to
transfer electrons from quinol to oxygen: heme b558, heme
b595 and heme d. The low spin heme b558 is believed to be the
entry site of electrons from quinol and is located near the puta-
tive quinol binding site. Heme d is the site where oxygen binds
and is reduced to water. The role of the high spin heme b595 is
still not clear, but heme b595 is located about 10 A˚ from the high
spin heme d [10] and minimally its role is to provide an electron
to facilitate the reduction of oxygen bound to heme d. The
membrane potential appears to be generated essentially by pro-
ton uptake accompanying the electron transfer from heme b558
to the oxygenated heme b595/heme d center, which generates a
product with a high aﬃnity for protons [8].
The isolated cytochrome bd appears to have a single binding
site for quinols. Unlike the heme–copper oxidases that utilize
ubiquinol as a substrate, such as cytochrome bo3 from
E. coli, there is no evidence for a tightly bound quinone which
does not readily exchange with the quinone pool in the mem-
brane. Hence, the isolated cytochrome bd has no bound qui-
none and the fully reduced form of the enzyme contains
three electrons for redox chemistry, corresponding to the fer-
rous forms of each of the three hemes.
Four diﬀerent states of heme d have been characterized spec-
troscopically in cytochrome bd. These are (1) ferric (Fe3+); (2)
ferrous (Fe2+); (3) ferrous–oxy complex (Fe2+–O2) and (4) oxo-
ferryl (Fe4+‚O2). A putative peroxy complex (supposedly,
Fe3+–OOH) has been observed recently as a transient interme-
diate during oxidation of the fully reduced enzyme by O2 [11],
but its structure requires further conﬁrmation. Each of the
other four forms of heme d can be generated as stable or meta-
stable forms that can be examined and characterized. These
forms suggest a sequence of events at heme d as O2 is converted
to water
Fe2þ !
þO2
Fe2þO2 !þeþHþ Fe
3þOAOH !
þeþHþH2O
Fe4þ@O2 !
þeþ2HþH2O
Fe3þ !
þe
Fe2þ ð1Þ
The analysis of enzyme turnover, however, must take into ac-
count the redox status of the other two heme prosthetic
groups, heme b558 and heme b595, which can exist in either
the Fe2+ or Fe3+ states, and also the fact the ubiquinol is a
two-electron donor.blished by Elsevier B.V. All rights reserved.
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posal based on the steady-state kinetics studies [12,13] that
the fully oxidized (b3þ558b
3þ
595d
3þ) form of cytochrome bd may
not be part of the catalytic cycle (Fig. 1).
The model shown in Fig. 1 implies that the rate of reduction
of the all-ferric form of the enzyme should be slow. Contrary
to this proposal, fast reduction of heme d in the all-ferric en-
zyme was observed in pulse radiolysis studies [14]. The gener-
ation of a strong one-electron reductant in this experiment
resulted in very rapid reduction of heme b558, equilibration
within 10 ls between heme b558 and heme b595, followed by
electron transfer to heme d with the rate constants of about
3400 s1 and 590 s1, for the ferric and the oxoferryl forms,
respectively. The one-electron transfer to heme d in the fer-
rous–oxy form (Fe2+–O2) was about 100-fold slower than ob-
served with the ferric and oxoferryl forms. Taken at face value,
these data suggest that the all-ferric form should be reconsid-
ered as a possible intermediate during steady state analysis,
and raises questions about the catalytic competence of the fer-
rous–oxy complex as an intermediate. An important diﬀerence
between the steady-state turnover and pulse radiolysis experi-
ments is that the former normally utilizes a two-electron donor
whereas the latter utilizes a one-electron reductant. This was
pointed out by Kobayashi et al. [14], in reference to the slow
single-electron transfer to the ferrous–oxy complex.
In the current work, a rapid mixing/diode array spectropho-
tometer was used to monitor the rate of reaction of ubiquinol-
1 (UQH2-1) and of ascorbate-reduced N,N,N
0,N 0-tetramethyl-
p-phenylendiamine (TMPD) with the all-ferric form of cyto-
chrome bd. The kinetics of these reactions were compared with
the reactions with the oxoferryl formof the enzyme generated by
transient oxidation of the fully-reduced cytochrome bd by a stoi-
chiometric amount of oxygen. The results reveal very slow (sec-
onds) reduction of the all-ferric enzyme by ubiquinol-1, whereas
reduction of the oxoferryl form of cytochrome bd is at leastFig. 1. Catalytic cycle of ubiquinol-oxidase activity of cytochrome bd. The
Matsumoto et al. [13].1000-fold more rapid and compatible with the turnover number
of the enzyme.With a single-electron donor TMPD, the oxofer-
ryl form of cytochrome bd is also a much better electron accep-
tor than the all-ferric form, however, the diﬀerence is much less
pronounced than in the case of two-electron reductant UQH2-1.
The data show directly that the all-ferric form of the enzyme is
not likely to be part of the normal catalytic cycle.2. Materials and methods
2.1. Strains and plasmids
E. coli strain GO105 (cyd AB::kan, cyo, recA), which lacks both the
cytochrome bo3 and cytochrome bd quinol oxidases [15], was used as
the host strain for overexpressing the wild type cytochrome bd from
plasmid pTK1 [15] which was introduced into the strain.
2.2. Cell growth and enzyme puriﬁcation
Large scale cell growth was carried out in 24 2 L ﬂasks shaking at
220 rpm and 37 C using an Innova 4330 incubator shaker (New Bruns-
wick Scientiﬁc) [16]. Cytochrome bd was puriﬁed as described previously
[17]. The pooled fractions were concentrated using anAmicon concentra-
tor with a 50 kDa molecular weight cut-oﬀ ﬁlter and then dialyzed three
times against 50 mM sodium phosphate buﬀer, pH 7.8, containing 5 mM
ethylenediaminetetraacetic acid (EDTA), 0.05% N-lauroylsarcosine.
2.3. Heme analysis
The heme b content of puriﬁed cytochrome bd was measured by the
pyridine hemochromogen assay, using an extinction coeﬃcient for the
wavelength pair 556.5540 nm, De556.5–540 = 24 mM1 cm1 [18]. The
heme d content and enzyme concentration were determined from the
absolute spectrum of the fully reduced enzyme, using the extinction
coeﬃcient De628–670 = 25 mM
1 cm1 [8].
2.4. Ubiquinol-1 and TMPD oxidase activity assays
The steady state oxidase activity assays were performed as described
previously by Zhang et al. [17]. The puriﬁed enzyme had a turnover
number of about 1100 s1 with 100 lM UQH2-1 + 3 mM dithiothrei-
tol (DTT) and about 160 s1 with 10 mM ascorbate + 0.5 mM TMPD.scheme is based on the work of Ju¨nemann et al. [12] as modiﬁed by
Fig. 2. Kinetics of reduction of heme d in the oxoferryl and the all-
ferric forms of cytochrome bd. Panel A. Reduction by UQH2-1: heme d
in the oxoferryl form is reduced within about 10 ms, compatible with
the turnover of the enzyme. No signiﬁcant reduction of heme d in the
all-ferric enzyme is observed in the same time range. Panel B.
Reduction by TMPD: the reduction of the all-ferric form is
signiﬁcantly slower than the reduction of heme d in the oxoferryl
form of the enzyme. Heme d in the oxoferryl form is reduced by
TMPD much more slowly than with UQH2-1, see Section 2 for details.
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Static absorbtion spectra were obtained with a UV-2101PC spectro-
photometer (Shimadzu).
2.6. Stopped-ﬂow experiments
The stopped-ﬂow experiments were performed at 20 C using an Ap-
plied Photophysics stopped ﬂow with a photodiode array detector. The
ﬂow system was ﬂushed thoroughly with argon-saturated buﬀer
(50 mM sodium phosphate, 5 mM EDTA and 0.05% N-lauroylsarco-
sine, pH 7.8) before the experiments. The whole system was kept
anaerobic by ﬂowing argon during the experiments. The mixing ratio
of the two solutions was 1:1. After mixing, 1600 spectra were collected
in the 300–1200 nm range over a period ranging from 2 s to 1 min. At
least three runs were performed for each time scale. The concentrations
reported are the initial concentrations before mixing, if not stated
otherwise.
2.7. Generation of the oxoferryl form of the enzyme
Five micromolar of enzyme was fully reduced by 200 lM ubiqui-
none-1 + 6 mM dithiothreitol or by 1 mM TMPD + 20 mM ascorbate
in an argon-saturated buﬀer (50 mM sodium phosphate, 5 mM EDTA
and 0.05% N-lauroylsarcosine, pH 7.8). The fully reduced enzyme
(b2þ558b
2þ
595d
2þ) was then rapidly mixed in the stopped-ﬂow apparatus
with an equal volume of a solution containing approximately 5 lM
O2 in the same buﬀer. The reduced cytochrome bd was rapidly oxidized
by O2 yielding essentially the oxoferryl form of the enzyme
(b3þ558b
3þ
595d
4þ@O2), which was subsequently reduced by the excess
reductant present in the solution. The oxidation reaction is too fast
to resolve, but the tail end of the reduction kinetics could be observed
spectroscopically. Spectroscopic analysis of the product of the reaction
of O2 with the reduced enzyme showed that it contained approximately
80% oxoferryl and 20% ferrous–oxy complex (not shown).
2.8. Experiments with the all-ferric form of cytochrome bd
Five micromolar of the ‘‘as isolated’’ cytochrome bd, mainly present
as ferrous–oxy complex b3þ558b
3þ
595d
2þAO2, was incubated for 20 min with
16 lM tetrachlorobenzoquinone, a lipophilic strong oxidant [19], in ar-
gon-saturated buﬀer (50 mM sodium phosphate, 5 mM EDTA and
0.05% N-lauroylsarcosine, pH 7.8). The incubation resulted in conver-
sion of the enzyme to the fully oxidized, all ferric form of the enzyme
(b3þ558b
3þ
595d
3þ). This form of the enzyme was rapidly mixed in the
stopped ﬂow with an equal volume of 200 lM ubiquinone-1 + 6 mM
DTT or, alternatively, 1 mM TMPD + 20 mM ascorbate, in order to
monitor the rate of reduction of the all-ferric form of the enzyme. A
strongly lipophilic tetrachlorobenzoquinone is expected to be an antag-
onist of UQH2-1 ubiquinol. Indeed, turnover of cytochrome bd with
100 lMUQH2-1 as electron donor in the presence of 16 lM tetrachlo-
robenzoquinone was decreased by 30–40% (to about 600–800 e s1).
There was no eﬀect of tetrachlorobenzoquinone on the ascor-
bate + TMPD-oxidase activity of the enzyme.
2.9. Data analysis
The data were ﬁrst analyzed with the use of Pro-Kineticist software
package ‘‘ProK for PC’’ (Applied Photophysics) and selected data
were imported into Origin 7 (Microcal) for further analysis and prep-
aration of the ﬁgures.3. Results
Fig. 2A compares the kinetics of reduction of heme d in the
oxoferryl and all-ferric forms of cytochrome bd. From the spec-
tra/time surface collected, the kinetics at a wavelength pair
628 nm and 719 nm (DA628–719) was extracted to monitor the
reduction of heme d. The kinetics of the reduction of the all-
ferric form of the enzyme by UQH2-1 is extremely slow and
non-homogeneous, reaching only about 25% of the expected
maximum in 2 s, the maximal observation period in the exper-
iment shown. This is in contrast to the extremely rapid reduc-
tion of heme d in the all-ferric enzyme (k  3400 s1),reported in the pulsed radiolysis experiments of Kobayashi
et al. [14]. Reduction of hemes b558 and b595 in the same exper-
iment was even slower that reduction of heme d, with either
DTT + ubiquinol or ascorbate + TMPD as electron donors
(data not included) and took about 60 s for completion,
whereas heme d reduction was complete in 20–30 s. Hence, it
is likely that it is electron entry into the enzyme (reduction of
b558), rather than intramolecular electron transfer, that limits
the rate of reduction of ferric heme d in the all-ferric enzyme.
In order to examine the reactivity of the oxoferryl state of
cytochrome bd, this form of the enzyme was generated
in situ in the stopped ﬂow mixing chamber by oxidation of
the fully reduced cytochrome bd with stoichiometric amount
of O2
b2þ558b
2þ
595d
2þ þO2 ¢ b2þ558b2þ595d2þAO2 ð2Þ
2Hþ þ ðb2þ558b2þ595d2þAO2Þ ! ðb3þ558b3þ595d4þ@O2Þ þH2O ð3Þ
Formation of the oxycomplex (reaction 2) and subsequent oxi-
dation of the reduced cytochrome bd by bound oxygen (reac-
tion 3) are complete within the mixing time, in agreement
with the known rate constants. At 2.5 lM oxygen (ﬁnal con-
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O2 is about 2 · 109 M1 s1 · 2.5 lM O2 = 5 · 103 s1, s
200 ls (see [20]), and the oxidation yields largely the oxofer-
ryl state of the enzyme (at least 80%). This was most clearly
seen in the spectra from the experiments in which reduced
TMPD was used as the reductant (data not shown), since the
subsequent reduction of the enzyme in this case is much slower
than with UQH2-1.
The oxoferryl form of the enzyme is reduced quite rapidly by
UQH2-1, and the reaction is completed in about 10 ms
(Fig. 2A). During this time, up to 12 time-resolved spectra
could be collected. The major part of the transiently oxidized
cytochrome bd is actually reduced within the dead time of
the mixing apparatus and only the tail end of this rapid reduc-
tion could be monitored with the current instrumentation.
Global analysis of the spectra/time surface for the resolved
part of the reduction process gave a rate constant of 200–
300 s1, which is close to enzyme turnover rate (1000 elec-
trons s1) when multiplied by four electrons required to con-
vert enzyme from the oxoferryl to the all ferrous state.
The diﬀerence spectrum of the rapid phase of the reduction,
as resolved by global analysis, is shown in Fig. 3. The spectrum
shows clearly simultaneous disappearance of the oxoferryl
state (trough around 670–680 nm) and appearance of reduced
heme d (peak at 630 nm), as well as reduced heme b558 and
heme b595 (the peaks at 595, 560 and 530 nm in the visible,
and an asymmetric Soret band with a maximum at 431 nm
and a shoulder around 438 nm). These data imply that the
reaction monitored involves reduction of the enzyme by two
equivalents of UQH2-1, since four electrons are required to
generate the fully reduced form of the enzyme (b2þ558b
2þ
595d
2þ)
from the oxoferryl state (b3þ558b
3þ
595d
4þ@O2) . The ﬁrst equiva-
lent of UQH2-1 produces a partially reduced form of the en-
zyme (b3þ558b
3þ
595d
2þ), so these results imply that the rate of
reduction by the second equivalent of UQH2-1 of the partially
reduced enzyme (b3þ558b
3þ
595d
2þ) is about as fast as the reaction of
the oxoferryl species (b3þ558b
3þ
595d
4þ@O2) with the ﬁrst equivalent
of UQH2-1.Fig. 3. Diﬀerence spectrum of the rapidly reduced component of
cytochrome bd in the reaction of the oxoferryl form reduced by UQH2-
1 found by global analysis of the spectra/time surface. The spectrum is
that of major product of the reaction formed in the ﬁrst 50 ms minus
the initial spectrum, which is primarily the oxoferryl form of the
enzyme. The conditions correspond to the trace shown in Fig. 2A.The reduction kinetics of the enzyme with a single electron
donor TMPD reduced by excess ascorbate was also examined
(Fig. 2B). Reduction of the all-ferric enzyme in this case is also
very slow. As in the case of ubiquinol, the reaction of reduced
TMPD with the oxoferryl form is more rapid than with the all-
ferric form of the enzyme, although it is still much slower than
observed with UQH2-1. The reduction of the all-ferric cyto-
chrome bd by reduced TMPD occurs on a time scale of 0.1–
0.5 s, not in milliseconds. It cannot be excluded that the reac-
tion of cytochrome bd with reduced TMPD is rate-limited by
the oxidation of TMPD, i.e., TMPD is a much poorer electron
donor than UQH2-1.4. Discussion
The data clearly show that the reduction of heme d in the
oxidized (all-ferric) form of cytochrome bd by its natural
two-electron substrate, ubiquinol, is much too slow to be part
of the catalytic cycle. In contrast, the reaction of the oxoferryl
form of cytochrome bd with ubiquinol is rapid and results in
formation of the fully reduced enzyme. Presumably, the reac-
tion proceeds in two sequential two-electron steps which are
not time-resolved under the conditions of our experiments at
a UQH2-1 concentration of 100 lM (the ﬁnal concentration
after mixing)
UQH2-1þ ðb3þ558b3þ595d4þ@O2Þ ¢ UQ-1þH2O
þ ðb2þ558b2þ595d2þÞ ð4Þ
UQH2-1þ ðb3þ558b3þ595d2þÞ ¢ UQ-1þ ðb2þ558b2þ595d2þÞ ð5Þ
The rate of reaction 5 must be at least as fast as reaction 4 un-
der the conditions of these experiments, since the appearance
of reduced heme d and the reduced hemes b occur in the same
time window. However, in the presence of excess of O2, the
very rapid rate of binding of O2 with the one-electron reduced
enzyme (microseconds) is expected to result in formation of the
one-electron ferrous–oxy complex
ðb3þ558b3þ595d2þÞ þO2 ¢ ðb3þ558b3þ595d2þAO2Þ ð6Þ
Hence, when the concentration of O2 is high, reaction 6 would
prevail, followed by reaction
ðb3þ558b3þ595d2þAO2Þ þUQH2-1 ¢ ðb2þ558b2þ595d2þAO2Þ ð7Þ
The product of reaction 7 has suﬃcient electrons to split the
O–O bond (reaction 3), provided protons are available.
Under microaerophilic growth conditions, in which cyto-
chrome bd is normally expressed in E. coli [21], the reactions
of the one-electron reduced enzyme (b3þ558b
3þ
595d
2þ) with O2 (reac-
tion 6) and with UQH2-1 (reaction 5) might occur in the re-
verse order, which, however, makes no diﬀerence to the ﬁnal
outcome of the reaction cycle. It is interesting that the heme
d ferrous–oxy complex (b3þ558b
3þ
595d
2þAO2) is very stable, being
the major form of the enzyme as it is isolated [22]. The disso-
ciation of oxygen in the form of superoxide (O2 ), which would
be deleterious to the cell, is negligible. On the other hand, two-
electron reduction of the all-ferric cytochrome bd by UQH2
and its subsequent oxidation by oxygen could give rise to an
unstable peroxide adduct of the ferric enzyme that could disso-
ciate releasing hydrogen peroxide, or produce hydroxyl radi-
cals in case of homolytic scission of the O–O bond. Hence,
the intermediate states of cytochrome bd with an odd number
K. Yang et al. / FEBS Letters 582 (2008) 3705–3709 3709of electrons relative to the all-ferric form appear to be pre-
ferred in the catalytic cycle of the enzyme. These catalytic
intermediate forms contain +3, +1 and 1 electrons relative
to the all-ferric enzyme: (a) +3 electrons = all-ferrous
ðbþ2558bþ2595dþ2Þ; (b) +1 electron = oxycomplex ðbþ3558bþ3595dþ2AO2Þ;
(c) 1 = oxoferryl ðbþ3558bþ3595dþ4@O2Þ.
The expectation from the previous work of Ju¨nemann et al.
[12] and of Matsumoto et al. [13], based on steady-state kinet-
ics, that the all-ferric form of cytochrome bd is not part of the
catalytic cycle of the enzyme is directly veriﬁed by pre-steady-
state kinetics. It remains to be seen why the one-electron reduc-
tant formed during the pulsed radiolysis experiments by
Kobayashi et al. [14] reacts with the all-ferric enzyme rapidly.
The explanation might be simply that the N-methylnicotina-
mide radical and solvated electron generated under the condi-
tions of pulse radiolysis are much stronger reductants than the
one-electron donor used in the current work, TMPD
(E0

m ¼ 260 mV) as well as than the ubiquinol/ubisemiquinone
couple that serves as an initial reductant for cytochrome bd
during the reaction of the enzyme with ubiquinol. One might
also note, that the all-ferric forms of cytochrome bd were ob-
tained in this work and in Ref. [14] by diﬀerent methods, but
it is highly unlikely that a variance in the preparations can ac-
count for the 1000-fold diﬀerence in reactivity of heme d.
The observation that UQH2-1 is a poor reductant for the all-
ferric form of the enzyme, but a good reductant for the oxofer-
ryl ðb3þ558b3þ595d4þAO2Þ and one-electron reduced enzyme
(b3þ558b
3þ
595d
2þ) suggests that the redox state of heme d plays a role
in determining the rate of reduction of heme b558 (and, per-
haps, of heme b595 as well). Further work is needed to clarify
the mechanism of this eﬀect. Recent work has shown that
the redox state of heme b558 and heme b595 regulates the acces-
sibility of heme d by O2 [23], thus, reciprocal regulation of the
reactivity of the two hemes b by the redox and/or ligand-bind-
ing state of heme dmay be a reasonable speculation. Evidently,
the interactions between the three hemes play a critical role in
determining the sequence of reactions in the catalytic cycle.
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